Market Closed -
Toronto S.E.
04:00:00 2024-05-15 pm EDT
|
5-day change
|
1st Jan Change
|
3.83
CAD
|
+0.26%
|
|
-3.28%
|
-0.52%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
179.6
|
1,307
|
1,022
|
653.6
|
929.5
|
941.3
|
-
|
-
|
Enterprise Value (EV)
1 |
168.7
|
1,307
|
1,297
|
898
|
1,231
|
1,220
|
1,206
|
1,107
|
P/E ratio
|
-19.5
x
|
-268
x
|
-21.3
x
|
-
|
-
|
255
x
|
-
|
38.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
5.48
x
|
26
x
|
3.38
x
|
1.15
x
|
1.2
x
|
0.97
x
|
0.89
x
|
0.86
x
|
EV / Revenue
|
5.14
x
|
26
x
|
4.29
x
|
1.58
x
|
1.59
x
|
1.26
x
|
1.13
x
|
1.01
x
|
EV / EBITDA
|
-98.5
x
|
-14,209
x
|
21.5
x
|
8.59
x
|
10.9
x
|
9.56
x
|
8.01
x
|
7.02
x
|
EV / FCF
|
-
|
-201
x
|
66.2
x
|
12.8
x
|
21.1
x
|
18.8
x
|
14.7
x
|
14.6
x
|
FCF Yield
|
-
|
-0.5%
|
1.51%
|
7.81%
|
4.74%
|
5.31%
|
6.79%
|
6.85%
|
Price to Book
|
0.05
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
115,159
|
162,404
|
208,166
|
230,153
|
241,428
|
245,760
|
-
|
-
|
Reference price
2 |
1.560
|
8.050
|
4.910
|
2.840
|
3.850
|
3.830
|
3.830
|
3.830
|
Announcement Date
|
3/31/20
|
3/18/21
|
3/31/22
|
3/21/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
32.81
|
50.24
|
302.3
|
569.1
|
776.1
|
969.8
|
1,064
|
1,094
|
EBITDA
1 |
-1.713
|
-0.092
|
60.36
|
104.6
|
113.4
|
127.7
|
150.6
|
157.7
|
EBIT
1 |
-6.086
|
-10.41
|
-12.79
|
23.31
|
-
|
52.44
|
86.49
|
122.2
|
Operating Margin
|
-18.55%
|
-20.71%
|
-4.23%
|
4.1%
|
-
|
5.41%
|
8.13%
|
11.17%
|
Earnings before Tax (EBT)
1 |
-7.759
|
-6.986
|
-24.97
|
17.92
|
-
|
22.54
|
47.63
|
81.7
|
Net income
1 |
-7.819
|
-3.686
|
-43.79
|
1.369
|
-
|
1.184
|
15.36
|
25
|
Net margin
|
-23.83%
|
-7.34%
|
-14.48%
|
0.24%
|
-
|
0.12%
|
1.44%
|
2.28%
|
EPS
2 |
-0.0800
|
-0.0300
|
-0.2300
|
-
|
-
|
0.0150
|
-
|
0.1000
|
Free Cash Flow
1 |
-
|
-6.517
|
19.59
|
70.14
|
58.33
|
64.78
|
81.81
|
75.8
|
FCF margin
|
-
|
-12.97%
|
6.48%
|
12.32%
|
7.52%
|
6.68%
|
7.69%
|
6.93%
|
FCF Conversion (EBITDA)
|
-
|
-
|
32.45%
|
67.08%
|
51.44%
|
50.74%
|
54.34%
|
48.07%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
5,123.59%
|
-
|
5,473.88%
|
532.48%
|
303.2%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/31/20
|
3/18/21
|
3/31/22
|
3/21/23
|
3/21/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
115.7
|
126.5
|
140.3
|
145.8
|
156.5
|
169.4
|
170.9
|
204.5
|
231.2
|
231.6
|
236.1
|
244.9
|
257.6
|
256.1
|
259.6
|
EBITDA
1 |
25.68
|
23.49
|
26.43
|
27.46
|
27.17
|
26.68
|
27.79
|
28.17
|
30.75
|
28.31
|
29.56
|
33.13
|
36.61
|
33.82
|
34.77
|
EBIT
1 |
6.848
|
7.374
|
6.324
|
8.578
|
2.288
|
8.759
|
10.11
|
7.079
|
-
|
8.853
|
10.76
|
14.81
|
18.52
|
18.18
|
19.14
|
Operating Margin
|
5.92%
|
5.83%
|
4.51%
|
5.88%
|
1.46%
|
5.17%
|
5.91%
|
3.46%
|
-
|
3.82%
|
4.56%
|
6.05%
|
7.19%
|
7.1%
|
7.37%
|
Earnings before Tax (EBT)
1 |
2.287
|
-0.039
|
-3.025
|
3.785
|
18.36
|
-10.44
|
-0.127
|
-4.507
|
-
|
19.42
|
0.0617
|
2.504
|
8.638
|
9.5
|
10.5
|
Net income
1 |
-8.803
|
-8.019
|
-5.903
|
-4.419
|
20.63
|
-14.36
|
-5.767
|
-7.606
|
-
|
15.09
|
-3.431
|
-1.251
|
1.864
|
4.974
|
5.627
|
Net margin
|
-7.61%
|
-6.34%
|
-4.21%
|
-3.03%
|
13.18%
|
-8.47%
|
-3.37%
|
-3.72%
|
-
|
6.52%
|
-1.45%
|
-0.51%
|
0.72%
|
1.94%
|
2.17%
|
EPS
2 |
-0.0400
|
-0.0400
|
-0.0300
|
-0.0200
|
0.0900
|
-0.0600
|
-0.0300
|
-0.0300
|
-
|
0.0600
|
-0.0100
|
-
|
0.0133
|
0.0100
|
0.0100
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/31/22
|
5/11/22
|
8/11/22
|
11/10/22
|
3/21/23
|
5/12/23
|
8/10/23
|
11/14/23
|
3/21/24
|
5/8/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
275
|
244
|
302
|
279
|
264
|
165
|
Net Cash position
1 |
10.9
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
4.549
x
|
2.337
x
|
2.66
x
|
2.186
x
|
1.756
x
|
1.049
x
|
Free Cash Flow
1 |
-
|
-6.52
|
19.6
|
70.1
|
58.3
|
64.8
|
81.8
|
75.8
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
33.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-0.0300
|
-0.0400
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.47
|
1.13
|
2.68
|
6.4
|
8.11
|
7.77
|
8.38
|
9.2
|
Capex / Sales
|
1.44%
|
2.26%
|
0.89%
|
1.13%
|
1.04%
|
0.8%
|
0.79%
|
0.84%
|
Announcement Date
|
3/31/20
|
3/18/21
|
3/31/22
|
3/21/23
|
3/21/24
|
-
|
-
|
-
|
Last Close Price
3.83
CAD Average target price
7.45
CAD Spread / Average Target +94.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.52% | 692M | | -28.75% | 70.63B | | +2.04% | 27.05B | | -6.19% | 17.97B | | +2.32% | 17.58B | | +2.10% | 15.64B | | +7.06% | 13.55B | | +10.80% | 13.41B | | +71.31% | 13.18B | | +75.96% | 12.99B |
Other Healthcare Facilities & Services
|